Cambrex Completes Acquisition of Halo Pharma
September 12, 2018 08:45 ET
|
Cambrex Corporation
EAST RUTHERFORD, N.J., Sept. 12, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs),...
Cambrex to Present at Upcoming Investor Conferences in September
August 29, 2018 08:10 ET
|
Cambrex Corporation
EAST RUTHERFORD, N.J., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs),...
Cambrex Reports Second Quarter 2018 Financial Results
August 02, 2018 06:40 ET
|
Cambrex Corporation
- Net Revenue increased 13% vs. prior year quarter, which includes a favorable impact from the adoption of ASC 606 - - 2018 full year Adjusted Net Revenue Growth and Adjusted EBITDA...
Cambrex to Announce Second Quarter 2018 Financial Results on August 2, 2018
July 27, 2018 11:10 ET
|
Cambrex Corporation
EAST RUTHERFORD, N.J., July 27, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs),...
Cambrex to Acquire Halo Pharma, Adding Drug Development and Finished Dosage Capabilities to Global API Manufacturing Network
July 23, 2018 06:40 ET
|
Cambrex Corporation
-- Conference Call at 8:30 a.m. ET Today -- EAST RUTHERFORD, N.J., July 23, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic...
Cambrex Expands Generic API Research and Development Capabilities at Milan, Italy Site
June 12, 2018 08:00 ET
|
Cambrex Corporation
EAST RUTHERFORD, N.J., June 12, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs),...
Cambrex to Present at the Jefferies 2018 Global Healthcare Conference
June 01, 2018 09:50 ET
|
Cambrex Corporation
EAST RUTHERFORD, N.J., June 01, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs),...
Cambrex Invests $5 Million in New Laboratory Expansion at its Karlskoga, Sweden Facility
May 31, 2018 08:00 ET
|
Cambrex Corporation
EAST RUTHERFORD, N.J., May 31, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs),...
Cambrex Completes Pilot Plant Expansion at its High Point, NC Facility
May 15, 2018 08:00 ET
|
Cambrex Corporation
EAST RUTHERFORD, N.J., May 15, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs),...
Cambrex Reports First Quarter 2018 Financial Results
May 03, 2018 06:45 ET
|
Cambrex Corporation
- Net Revenue increased 34% vs. prior year quarter, which includes a favorable impact from the adoption of ASC 606 - - 2018 full year financial guidance reaffirmed - - Conference call at 8:30 a.m....